Methodological approach to investigate peroxiredoxin 1 deacetylation by histone deacetylase 6
Methods in Enzymology · 2026
DOI: 10.1016/bs.mie.2026.05.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods in Enzymology, 2026. Verfasst von Sonali Kumar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Lingaya's Vidyapeeth, Faridabad, Haryana, India; Dr. B. R. Ambedkar Centre for Biomedical Research, University of Delhi,…. Hauptthemen laut MEDLINE: Peroxiredoxins, Histone Deacetylase 6, Histone Deacetylases. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Lingaya's Vidyapeeth, Faridabad, Haryana, India; Dr. B. R. Ambedkar Centre for Biomedical Research, University of Delhi, Delhi, India.
- Dr. B. R. Ambedkar Centre for Biomedical Research, University of Delhi, Delhi, India; All India Institute of Ayurveda (AIIA), Government of India, New Delhi, India.
- Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India.
- Dr. B. R. Ambedkar Centre for Biomedical Research, University of Delhi, Delhi, India. Electronic address: aparnabanerjeedixit@gmail.com.
Zitieren
APA
Kumar, S., Shanker, O. R., Banerjee, J., & Dixit, A. B. (2026). Methodological approach to investigate peroxiredoxin 1 deacetylation by histone deacetylase 6. Methods in Enzymology. https://doi.org/10.1016/bs.mie.2026.05.040
Vancouver
Kumar S, Shanker OR, Banerjee J, Dixit AB. Methodological approach to investigate peroxiredoxin 1 deacetylation by histone deacetylase 6. Methods in Enzymology. 2026. doi:10.1016/bs.mie.2026.05.040
BibTeX
@article{Kumar2026,
author = {Kumar, Sonali and Shanker, Ozasvi R and Banerjee, Jyotirmoy and Dixit, Aparna Banerjee},
title = {Methodological approach to investigate peroxiredoxin 1 deacetylation by histone deacetylase 6},
journal = {Methods in Enzymology},
year = {2026},
doi = {10.1016/bs.mie.2026.05.040}
}
EUVIMED